Foto del docente

Francesca Fornari

Associate Professor

Department for Life Quality Studies

Academic discipline: BIOS-09/A Clinical Biochemistry and Clinical Molecular Biology

Publications

Vianello, C.; Leoni, I.; Galvani, G.; Monti, E.; Marisi, G.; Casadei Gardini, A.; Foschi, G. F.; Stefanelli, C.; Gramantieri, L.; Fornari, F., miR-30e-3p/CXCL3 axis predicts early tumor escape in sorafenib-treated HCC patients., in: Abstract Book EACR 2024, 2024(atti di: European Association for Cancer Research (EACR) congress 2024, Rotterdam, 10-13 giugno 2024) [Poster]

Giovannini, Catia; Suzzi, Fabrizia; Tovoli, Francesco; Bruccoleri, Mariangela; Marseglia, Mariarosaria; Alimenti, Eleonora; Fornari, Francesca; Iavarone, Massimo; Piscaglia, Fabio; Gramantieri, Laura, Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma, «CANCERS», 2023, 15, Article number: 1661 , pp. 1 - 13 [Scientific article]Open Access

Bergamini, Christian; Leoni, Ilaria; Rizzardi, Nicola; Melli, Mattia; Galvani, Giuseppe; Coada, Camelia Alexandra; Giovannini, Catia; Monti, Elisa; Liparulo, Irene; Valenti, Francesca; Ferracin, Manuela; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Piscaglia, Fabio; Negrini, Massimo; Stefanelli, Claudio; Fato, Romana; Gramantieri, Laura; Fornari, Francesca, MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma, «JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH», 2023, 42, Article number: 145 , pp. 1 - 23 [Scientific article]Open Access

Leoni, Ilaria; Galvani, Giuseppe; Bergamini, Christian; Rizzardi, Nicola; Melli, Mattia; Coada, Camelia Alexandra; Monti, Elisa; Giovannini, Catia; Liparulo, Irene; Ferracin, Manuela; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Piscaglia, Fabio; Negrini, Massimo; Stefanelli, Claudio; Fato, Romana; Gramantieri, Laura; Fornari, Francesca, MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma, in: Abstract Book - EASL Liver Cancer Summit 2023, 2023(atti di: EASL Liver Cancer Summit 2023, Estoril, Portugal, 20-22/04/2023) [Poster]

Galvani, G.; Leoni, I.; Bergamini, C.; Rizzardi, N.; Melli, M.; Coada, C. A.; Monti, E.; Giovannini, C.; Liparulo, I.; Ferracin, M.; Ravaioli, M.; Cescon, M.; Vasuri, F.; Piscaglia, F.; Negrini, M.; Stefanelli, C.; Fato, R.; Gramantieri, L.; Fornari, F., MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma, in: Digestive and Liver Disease Volume 55, Supplement 1, March 2023, Page S47, 2023(atti di: Abstracts of the 55th A.I.S.F. - Italian Association for the Study of the Liver - Annual Meeting 2023, Roma, 16-17/03/2023) [Poster]

Gramantieri L.; Gnudi F.; Vasuri F.; Mandrioli D.; Fornari F.; Tovoli F.; Suzzi F.; Vornoli A.; D'errico A.; Piscaglia F.; Giovannini C., Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area, «NUTRIENTS», 2022, 14, Article number: 1652 , pp. 1652 - 1663 [Scientific article]Open Access

Francesca Fornari; Catia Giovannini; Fabio Piscaglia; Laura Gramantieri, Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research, «JOURNAL OF HEPATOCELLULAR CARCINOMA», 2022, 9, pp. 1263 - 1278 [Scientific article]Open Access

Gramantieri, Laura; Leoni, Ilaria; Pollutri, Daniela; Galvani, Giuseppe; Giovannini, Catia; Suzzi, Fabrizia; Casadei-Gardini, Andrea; Callegari, Elisa; Vasuri, Francesco; Ravaioli, Matteo; Cescon, Matteo; Piscaglia, Fabio; Negrini, Massimo; Fornari, Francesca, MiR-30e-3p plays a dual role in hepatocellular carcinoma and predicts tumour escape to sorafenib Treatment, in: Abstract Book - 62nd Annual Meeting of the Italian Cancer Society: The exciting path from preclinical research to clinical application, 2022(atti di: 62nd Annual Meeting of the Italian Cancer Society: The exciting path from preclinical research to clinical application, Venezia, 16-18/11/2022) [Poster]

Gramantieri, Laura; Fornari, Francesca, MicroRNA as predictive biomarkers of treatment response to tyrosine kinase inhibitors in hepatocellular carcinoma: how much is missing?, «ONCOSCIENCE», 2022, 9, pp. 52 - 54 [Comment or similar]Open Access

Laura Gramantieri, Francesca Fornari, Catia Giovannini, Davide Trere, MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma, «BIOMOLECULES», 2022, 12(7), pp. 1 - 19 [Scientific article]Open Access

Fornari Francesca; Gramantieri Laura, Pathophysiology roles and translational opportunities of miRNAs in hepatocellular carcinoma, in: MicroRNA in Human Malignancy, Amsterdam, Elsevier, 2022, pp. 301 - 315 [Chapter or essay]

Fornari, F; Giovannini, C; Piscaglia, F; Gramantieri, L, Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions, «JOURNAL OF HEPATOCELLULAR CARCINOMA», 2021, 8, pp. 741 - 757 [Scientific article]Open Access

Gramantieri L.; Giovannini C.; Suzzi F.; Leoni I.; Fornari F., Hepatic cancer stem cells: Molecular mechanisms, therapeutic implications, and circulating biomarkers, «CANCERS», 2021, 13, Article number: 4550 , pp. 1 - 22 [Scientific article]Open Access

Gramantieri, L; Giovannini, C; Piscaglia, F; Fornari, F, MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma, «JOURNAL OF HEPATOCELLULAR CARCINOMA», 2021, 8, pp. 369 - 385 [Scientific article]Open Access

Giovannini C.; Fornari F.; Piscaglia F.; Gramantieri L., Notch signaling regulation in HCC: From hepatitis virus to non‐coding rnas, «CELLS», 2021, 10, Article number: 521 , pp. 1 - 20 [Scientific article]Open Access